COMPANY Data
Movers and SHAKERS

Ticker | PSYBF (OTO) |
Current Price | $0.08 ↑ 0.02 |
Market Cap | 8.80M |
Price Target | $2.00 |
Volume | 2.73k |
52wk Range | $0.04 - $0.56 |
ADVANCED MARKET DATA |

Advanced Market Data
PsyBio Therapeutics (PSYBF)





Overview
Noble Capital Markets research on PsyBio Therapeutics is published under ticker symbols PSYBF and PSYB:CA. The price target is in USD and based on ticker symbol PSYBF. PsyBio Therapeutics is fully integrated and intellectual property driven biotechnology company developing novel psychoactive medicinal candidates produced by genetically modified organisms targeting the potential treatment of mental health challenges, neurological disorders, and other human health conditions. The team has extensive experience in drug discovery based on synthetic biology and metabolic engineering as well as clinical and regulatory expertise progressing drugs through human studies and regulatory protocols. Research and development activities are currently ongoing for naturally occurring psychoactive tryptamines originally discovered in different varieties of hallucinogenic mushrooms, other tryptamines and phenethylamines and combinations thereof. The Company utilizes a bio-medicinal chemistry approach to therapeutic development, in which psycho-targeted compounds can be utilized as a template upon which to develop precursors and analogs, both naturally and non-naturally occurring, specifically because they are already known to have an effect within the brain.
- Industry/Sector Report
- Corporate Presentation
- Corporate Events
- Press Releases/News Feed
- ChannelCAST Videos
- Senior Equity Research Analyst
- Corporate Filings
PsyBio Therapeutics Corporate Filings
PsyBio Therapeutics Corporate Events
PsyBio Therapeutics Press Releases / News Feed
Channelchek
Not available
Channelchek
No reports available